chlorisondamine has been researched along with naloxone in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (68.75) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drüge, G; Lenz, HJ | 1 |
| Fisher, LA; Porreca, F; Qi, JA; Sheldon, RJ | 1 |
| Lenz, HJ | 1 |
| Amir, S; van Ree, JM | 1 |
| Drüge, G; Greten, H; Lenz, HJ; Raedler, A | 1 |
| Brown, MR; Hester, SE; Lenz, HJ; Saik, RP | 1 |
| Hoffman, BB; Maze, M; Prokocimer, PG | 1 |
| Gurll, NJ; Lechner, RB; Reynolds, DG | 1 |
| Brown, MR; Hester, SE; Lenz, HJ | 1 |
| Appel, NM; Ho, D; Van Loon, GR | 1 |
| Amir, S | 2 |
| Tyce, GM; Yaksh, TL | 1 |
| Koob, GF; Markou, A; Stinus, L; Watkins, SS | 1 |
| Decker, MW; Honore, P; Lynch, JJ; Mikusa, JP; Wade, CL | 1 |
| Honore, P; Joshi, SK; Mikusa, JP; Weaver, B | 1 |
16 other study(ies) available for chlorisondamine and naloxone
| Article | Year |
|---|---|
Neurohumoral pathways mediating stress-induced inhibition of gastric acid secretion in rats.
Topics: Adrenal Glands; Animals; Arginine Vasopressin; Bretylium Tosylate; Chlorisondamine; Corticotropin-Releasing Hormone; Ganglia, Sympathetic; Gastric Acid; Male; Naloxone; Neural Pathways; Neurotransmitter Agents; Pentagastrin; Pituitary Gland; Rats; Rats, Inbred Strains; Stress, Physiological; Vagus Nerve | 1990 |
Gastrointestinal motor effects of corticotropin-releasing factor in mice.
Topics: Adrenalectomy; Animals; Chlorisondamine; Corticotropin-Releasing Hormone; Dose-Response Relationship, Drug; Gastric Emptying; Gastrointestinal Transit; Injections, Intravenous; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Naloxone; Peptide Fragments | 1990 |
Neurohumoral pathways mediating stress-induced changes in rat gastrointestinal transit.
Topics: Adrenalectomy; Animals; Bretylium Compounds; Chlorisondamine; Gastric Emptying; Gastrointestinal Transit; Hypophysectomy; Male; Naloxone; Neural Pathways; Neurotransmitter Agents; Rats; Rats, Inbred Strains; Restraint, Physical; Stress, Physiological; Vagotomy | 1989 |
Beneficial effect of gamma-endorphin-type peptides in anaphylactic shock.
Topics: Anaphylaxis; Animals; beta-Endorphin; Chlorisondamine; Drug Interactions; Endorphins; gamma-Endorphin; Male; Mice; Mice, Inbred ICR; Naloxone; Peptide Fragments; Serum Albumin, Bovine; Sympathetic Nervous System | 1985 |
Pathways mediating CRF-induced inhibition of gastric acid secretion in rats.
Topics: Adrenalectomy; Animals; Bretylium Compounds; Chlorisondamine; Corticotropin-Releasing Hormone; Gastric Acid; Injections, Intravenous; Injections, Intraventricular; Kinetics; Male; Naloxone; Pentagastrin; Peptide Fragments; Rats; Rats, Inbred Strains; Vagotomy | 1989 |
CNS actions of calcitonin gene-related peptide on gastric acid secretion in conscious dogs.
Topics: Animals; Calcitonin Gene-Related Peptide; Chlorisondamine; Deoxyglucose; Dogs; Gastric Acid; Gastrins; Histamine; Kinetics; Male; Naloxone; Nerve Tissue Proteins; Pentagastrin; Peptide Fragments; Structure-Activity Relationship; Vagotomy; Vasopressins | 1986 |
Role of the sympathetic nervous system in the maintenance of hypertension in rats harboring pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Animals; Chlorisondamine; Clonidine; Hypertension; Naloxone; Pheochromocytoma; Rats; Sympathetic Nervous System | 1987 |
Naloxone potentiates the cardiovascular effects of catecholamines in canine hemorrhagic shock.
Topics: Adrenal Glands; Animals; Blood Pressure; Catecholamines; Chlorisondamine; Denervation; Dogs; Drug Synergism; Female; Heart Rate; Isoproterenol; Male; Naloxone; Phenylephrine; Shock, Hemorrhagic | 1985 |
Corticotropin-releasing factor. Mechanisms to inhibit gastric acid secretion in conscious dogs.
Topics: Animals; Arginine Vasopressin; Autonomic Nervous System; Chlorisondamine; Corticotropin-Releasing Hormone; Dogs; Eating; Gastric Acid; Gastrins; Male; Naloxone; Pentagastrin; Vagotomy; Vasopressins | 1985 |
beta-Endorphin-induced stimulation of central sympathetic outflow: beta-endorphin increases plasma concentrations of epinephrine, norepinephrine, and dopamine in rats.
Topics: Animals; beta-Endorphin; Chlorisondamine; Dopamine; Dose-Response Relationship, Drug; Endorphins; Epinephrine; Humans; Kinetics; Male; Naloxone; Norepinephrine; Rats; Sympathetic Nervous System | 1981 |
Beneficial effect of i.c.v. naloxone in anaphylactic shock is mediated through peripheral beta-adrenoceptive mechanisms.
Topics: Adrenal Medulla; Anaphylaxis; Animals; Chlorisondamine; Denervation; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Naloxone; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Sympathetic Nervous System | 1984 |
Antianaphylactic effect of naloxone in mice is mediated by increased central sympathetic outflow to sympathetic nerve endings and adrenal medulla.
Topics: Adrenal Medulla; Anaphylaxis; Animals; Chlorisondamine; Hydroxydopamines; Male; Mice; Naloxone; Oxidopamine; Sympathetic Nervous System | 1983 |
Monoamine release from cat spinal cord by somatic stimuli: an intrinsic modulatory system.
Topics: Animals; Cats; Chlorisondamine; Cold Temperature; Electric Stimulation; Methoxamine; Naloxone; Norepinephrine; Sciatic Nerve; Secretory Rate; Serotonin; Spinal Cord; Tyramine | 1981 |
Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects.
Topics: Animals; Brain; Chlorisondamine; Injections, Intraventricular; Male; Mecamylamine; Naloxone; Nicotine; Rats; Rats, Wistar; Receptors, Nicotinic; Reward; Substance Withdrawal Syndrome | 2000 |
ABT-594 (a nicotinic acetylcholine agonist): anti-allodynia in a rat chemotherapy-induced pain model.
Topics: Acetylcholine; Analgesia; Animals; Azetidines; Chlorisondamine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Therapy, Combination; Humans; Mecamylamine; Naloxone; Nicotinic Agonists; Pain; Pyridines; Rats; Rats, Sprague-Dawley; Time Factors; Vincristine | 2005 |
Morphine and ABT-594 (a nicotinic acetylcholine agonist) exert centrally mediated antinociception in the rat cyclophosphamide cystitis model of visceral pain.
Topics: Analgesics; Animals; Azetidines; Behavior, Animal; Brain; Chlorisondamine; Cyclophosphamide; Cystitis; Disease Models, Animal; Male; Mecamylamine; Morphine; Naloxone; Narcotic Antagonists; Nicotinic Antagonists; Pain; Pyridines; Quaternary Ammonium Compounds; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Viscera | 2008 |